Celltrion | 068270 - Le Bénéfice D'Exploitation

Prix De L'Action
202,000.00
Variation Quotidienne
0 0%
Mensuellement
-16.87%
Annuel
8.20%
Q1 Prévisions
191,374.80




Le Bénéfice D'Exploitation Changement Date
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Avita Medical AUD -10.41M 742K 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Moderna USD -857M 597M 2025-12
Organon & Co USD 388M 62M 2025-09
Revvity USD 145.83M 47.49M 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12